GlycA inflammation
Selected indexed studies
- GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. (J Transl Med, 2017) [PMID:29078787]
- GlycA as a Novel Biomarker of Systemic Inflammation in Hypothyroidism. (Thyroid, 2023) [PMID:37534852]
- The Inflammation Biomarker GlycA Reflects Plasma N-Glycan Branching. (Clin Chem, 2023) [PMID:36254612]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. (2017) pubmed
- GlycA as a Novel Biomarker of Systemic Inflammation in Hypothyroidism. (2023) pubmed
- The Inflammation Biomarker GlycA Reflects Plasma N-Glycan Branching. (2023) pubmed
- Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates. (2023) pubmed
- Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in Psoriasis. (2025) pubmed
- Genetic association of inflammatory marker GlycA with lung function and respiratory diseases. (2024) pubmed
- GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile. (2020) pubmed
- GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment. (2020) pubmed
- Multimarkers of metabolic malnutrition and inflammation and their association with mortality risk in cardiac catheterisation patients: a prospective, longitudinal, observational, cohort study. (2023) pubmed
- Plasma GlycA, a Glycoprotein Marker of Chronic Inflammation, and All-Cause Mortality in Cirrhotic Patients and Liver Transplant Recipients. (2025) pubmed